Clinical Trial Update: Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from an early-stage trial testing tumor ablation using talaporfin sodium and interstitial light-emitting diodes to treat hepatocellu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasms

Drugs mentioned

• talaporfin sodium (talaporfin sodium)

Snippet

Sponsor: Light Sciences Oncology | Conditions: Carcinoma, Hepatocellular, Liver Neoplasms | Phase 1, Phase 2 | Status: COMPLETED